UnitedHealth Group has remained a subject of active institutional attention through mid-2026. The company operates across managed care, pharmacy benefits, and health services segments, and has drawn continued scrutiny amid a broader environment of elevated healthcare costs and an active regulatory environment [Brief - 2026-07-11]. Briefings through July 2026 noted these themes as persistent features of the operating landscape for the company [Brief - 2026-07-03] [Brief - 2026-07-19].
As of the quarter ended 31 March 2026, UnitedHealth Group reported trailing twelve-month revenue of approximately $449.7 billion, reflecting year-over-year revenue growth of 1.96%. Net income on a TTM basis stood at $12.8 billion, with a net margin of 2.85% and an operating margin of 4.19%. EPS grew 0.73% year-over-year. The company held $28.0 billion in cash against total debt of $77.9 billion. The P/E ratio was recorded at 31.68, and market capitalisation stood at approximately $382.0 billion [SEC 10-Q - UNH - 2026-03-31].
Insider activity recorded nine transactions in July 2026, with a net direction characterised as mixed and a net value of zero, indicating no dominant directional signal from insiders during the period [SEC Form 4 - UNH - 2026-07]. Institutional position changes were notably divergent. Citadel reduced its UNH position by 19%, while Tiger Global reduced its position by 17%. Conversely, Millennium added 56% to its position, AQR Capital added 36%, and Soros Fund Management added 14% [SEC 13F - Citadel - Q2 2026] [SEC 13F - Millennium - Q2 2026] [SEC 13F - AQR Capital - Q2 2026] [SEC 13F - Tiger Global - Q2 2026] [SEC 13F - Soros Fund Mgmt - Q2 2026].
The prevailing macro environment as of the report date showed the 10-year US Treasury yield at 4.71% and the 2-year yield at 4.37%, producing a normal yield curve with a spread of 34 basis points [FRED DGS10] [FRED DGS2]. This report was generated in response to material institutional position changes across multiple prominent filers, as detailed in the ownership section above.